| Financial Year |
March 31 2023 |
| Monetary Funds |
417,573,012.14 |
| Held-for-trading Financial Assets |
80,121,786.30 |
| Notes Receivable |
101,764,014.49 |
| Accounts Receivable |
578,117,188.83 |
| Advances to Suppliers |
110,297,176.39 |
| Other Receivables |
42,258,127.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
299,260,644.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,133,238.30 |
| Total Current Assets |
1,770,947,550.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
714,805,952.74 |
| Under-construction Projects |
31,360,521.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,736,469.76 |
| R&D expenses |
-- |
| Goodwill |
141,592,464.57 |
| Long-Term Deferred and Prepaid Expenses |
43,470,122.49 |
| Deferred Income Tax Assets |
32,818,554.60 |
| Other Non-Current Assets |
3,498,556.39 |
| Sub-Total of Non-Current Assets |
1,088,040,284.68 |
| Total Assets |
2,858,987,834.76 |
| Short-Term Loans |
188,237,205.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,352,498.09 |
| Accounts Payable |
175,642,284.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,237,062.42 |
| Taxes Payable |
8,946,235.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,386,942.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,456,477.92 |
| Other Current Liabilities |
40,900,105.94 |
| Sub-Total of Current Liabilities |
727,854,593.94 |
| Long-term Loans |
218,099,950.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,163,205.58 |
| Deferred Income Tax Liabilities |
1,510,215.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
247,719,543.17 |
| Total Liabilities |
975,574,137.11 |
| Paid-In Capital(Or Share Stock) |
674,924,800.00 |
| Capital Surplus |
798,512,371.22 |
| Surplus Reserve |
101,324,115.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
276,613,535.48 |
| Minority Stockholder's Interest |
32,038,875.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,851,374,821.91 |
| Owner's Equity（Stockholder's Equity） |
1,883,413,697.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,858,987,834.76 |
